Nataliya V. Uboha

Aug 28, 2024 | medscape.com | Samuel J. Klempner |Nataliya V. Uboha

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Samuel J. Klempner, MD: Hello. My name is Dr Sam Klempner. I'm a gastrointestinal medical oncologist at Massachusetts General in Boston. Welcome to the Medscape InDiscussion esophageal cancer podcast series. I'm joined by my colleague, Dr Nataliya Uboha.

Dec 6, 2023 | accc-cancer.org | Nataliya V. Uboha

Gastric cancer is the fifth most common cancer and the fourth leading cause of death from cancer worldwide.1Occurrence of gastric cancer is linked toHelicobacter Pylori infection, as well as genetic risk factors, and lifestyle factors such as alcohol consumption and smoking. Due to ambiguous symptoms in early-stage gastric cancer and the lack of preventive screenings, gastric cancer is most often diagnosed at advanced stages of the disease.

Oct 3, 2023 | touchoncology.com | Jeremy D. Kratz |Nataliya V. Uboha

Gastrointestinal Cancers Read Time: 15 mins Copy Link Published Online: Oct 3rd 2023 touchREVIEWS in Oncology & Haematology. 2023;19(2):22-28 DOI: https://doi.org/10.17925/OHR.2023.19.2.1 Authors: Jeremy D Kratz, Nataliya V Uboha Quick Links: Overview Immune checkpoint inhibitors allow innate immune cells to recognize and attack tumour cells by removing inhibitory signals associated with tumours and their microenvironment.

May 5, 2023 | pubmed.ncbi.nlm.nih.gov | Min Cui |Nataliya V. Uboha

Skip to main page content Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day?